Sexual function in women with Polycystic Ovary Syndrome

Sexual function in women with Polycystic Ovary Syndrome - PCOS and sexual function

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54548

Enrollment

356

Registered

2016-06-23

Start date

2017-02-19

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: diagnosis of PCOS and age-matched controls (healthy women) age: 18-40 years stable heterosexual relationship for at least 6 months

Exclusion criteria

Exclusion criteria: a psychiatric disorder, pregnancy or lactation, having undergone a radical hysterectomy or prolaps surgery, current or recent use of medication or medical disorders (other than PCOS) that may influence sexual response.

Design outcomes

Primary

Measure	Time frame
1. General sexual function as measured with the FSFI, SDI, FSDS-R 2. Genital sexual responsiveness (VPA) and self-reported ratings of subjective sexual responsiveness and affect (7 point Likert scale) from the psychophysiological measurements.	—

Secondary

Measure	Time frame
1. The association between OCP use and general sexual function and genital sexual responsiveness. 2. The association between sexual parameters as measured with SESII-W, SPAQ and SES and genereal sexual function and genital sexual responsiveness. 3. Psychosocial parameters as measured with MBSRQ-AS, BISS, HADS, RSES and R-DAS 4. Steroid hormone levels (Testosterone, Sex Hormone Binding Globluline (SHBG) calculating Free Androgen Index: Testosterone x 100/SHBG), Oestradiol, Progesterone, Luteinizing-hormone (LH), FollicleStimulating-hormone (FSH), Androstedione, Dehydro-epiandrosterone (DHEA), Dehydro-epiandrosterone sulphate (DHEAS), Thyroid Stimulating Hormone (TSH), Prolactine, and fasting glucose and insulin) 5. Androgen receptor sensitivity as measured with CAG repeats	—

Measure

Time frame

1. The association between OCP use and general sexual function and genital sexual responsiveness. 2. The association between sexual parameters as measured with SESII-W, SPAQ and SES and genereal sexual function and genital sexual responsiveness. 3. Psychosocial parameters as measured with MBSRQ-AS, BISS, HADS, RSES and R-DAS 4. Steroid hormone levels (Testosterone, Sex Hormone Binding Globluline (SHBG) calculating Free Androgen Index: Testosterone x 100/SHBG), Oestradiol, Progesterone, Luteinizing-hormone (LH), FollicleStimulating-hormone (FSH), Androstedione, Dehydro-epiandrosterone (DHEA), Dehydro-epiandrosterone sulphate (DHEAS), Thyroid Stimulating Hormone (TSH), Prolactine, and fasting glucose and insulin) 5. Androgen receptor sensitivity as measured with CAG repeats

—

Countries

Netherlands

Outcome results